World Journal of Dentistry

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  15 (2024)
Volume  14 (2023)
Volume  13 (2022)
Volume  12 (2021)
Volume  11 (2020)
Volume  10 (2019)
Volume  9 (2018)
Volume  8 (2017)
Volume  7 (2016)
Volume  6 (2015)
Volume  5 (2014)
Volume  4 (2013)
Volume  3 (2012)
Volume  2 (2011)
Volume  1 (2010)
Related articles

VOLUME 15 , ISSUE 3 ( March, 2024 ) > List of Articles

REVIEW ARTICLE

Meth Mouth and its Dental Implications: A Scoping Review on Toothless Tale Phenomena

Shankargouda Patil, Jagadish Hosmani, Sushma Bommanavar, Abdulrahman Y Alshahrani, Shahrukh Khan

Keywords : Crystal meth, Dental caries, Drug-induced hyposalivation, Meth mouth, Methamphetamine abuse, Xerostomia

Citation Information : Patil S, Hosmani J, Bommanavar S, Alshahrani AY, Khan S. Meth Mouth and its Dental Implications: A Scoping Review on Toothless Tale Phenomena. World J Dent 2024; 15 (3):270-273.

DOI: 10.5005/jp-journals-10015-2086

License: CC BY-NC 4.0

Published Online: 20-04-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

Meth mouth, also known as methamphetamine-induced caries (MIC), is a condition that causes an early toothless situation in one's life. It is caused by a highly addictive, powerful, psychoactive stimulant drug called Methamphetamine (MA) that belongs to the family of Amphetamine-type stimulants (ATS). This induces a state of ecstasy and euphoria in long-term MA users. Oral effects of long-term use of this recreational party drug can cause poor oral hygiene, rampant caries, xerostomia, and excessive tooth wear. The present review is designed to summarize the current updates on dental implications among MA users and its mysterious pathogenesis involved in leading to the toothless condition. This update was produced carefully to synthesize evidence-based practices and practice-based evidence to assist dental practitioners to recognize this condition and elicit effective dental treatment plans.

PDF Share
  1. Murakawa N. Toothless: the methamphetamine “epidemic,” “meth mouth,” and the racial construction of drug scares. Du Bois Rev 2011;8(1):219–228. DOI: 10.1017/S1742058X11000208
  2. McKetin R, Chrzanowska A, Man N, et al. Trends in treatment episodes for methamphetamine smoking and injecting in Australia, 2003–2019. Drug Alcohol Rev 2021;40(7):1281–1286. DOI: 10.1111/dar.13258
  3. Smit DA, Naidoo S. Methamphetamine abuse: oral symptoms and dental treatment needs. S Afr Dent J 2016;71(4):150–154. Available from http://www.scielo.org.za/scielo.php?script=sci_arttext&pid=S0011-85162016000400003&lng=en
  4. UNODC. World Drug Report 2013.https://www.unodc.org/unodc/secured/wdr/wdr2013/World_Drug_Report_2013.pdf (accessed 28 April 2022)
  5. Pabst A, Castillo-Duque JC, Mayer A, et al. Meth mouth—a growing epidemic in dentistry? Dent J (Basel) 2017;5(4):29. DOI: 10.3390/dj5040029
  6. De-Carolis C, Boyd GA, Mancinelli L, et al. Methamphetamine abuse and “meth mouth” in Europe. Med Oral Patol Oral Cir Bucal 2015;20(2):e205–e210. DOI: 10.4317/medoral.20204
  7. UNDOC. Patterns and trends of Amphetamine-Type Stimulants and Other Drugs. https://www.unodc.org/documents/southeastasiaandpacific/2012/12/ats-2012/2012_Regional_ATS_Report_FINAL_HQPDF_3_Dec_2012_low.pdf (accessed 28 April 2022)
  8. Rommel N, Rohleder NH, Koerdt S, et al. Sympathomimetic effects of chronic methamphetamine abuse on oral health: a cross-sectional study. BMC Oral Health 2016;16(1):1–8. DOI: 10.1186/s12903-016-0218-8
  9. Kirby T, Thornber-Dunwell M. High-risk drug practices tighten grip on London gay scene. Lancet 2013;381(9861):101–102. DOI: 10.1016/s0140-6736(13)60032-x
  10. Olkkola KT, Ahonen J. Drug interactions. Curr Opin Anaesthesiol 2001;14(4):411–416. DOI: 10.1097/00001503-200108000-00006
  11. Maxwell JC, Rutkowski BA. The prevalence of methamphetamine and amphetamine abuse in North America: a review of the indicators, 1992–2007. Drug Alcohol Rev 2008;27(3):229–235. DOI: 10.1080/09595230801919460
  12. The faces of meth. Multnomah County Sheriff's Office. https://facesofmeth.us/ (accessed 28 April 2022)
  13. Faces of meth. PBS. Frontline. https://www.pbs.org/wgbh/pages/frontline/meth/body/faces.html (accessed 28 April 2022)
  14. Ravenel MC, Salinas CF, Marlow NM, et al. Methamphetamine abuse and oral health: a pilot study of “meth mouth”. Quintessence Int 2012;43(3):229–237. PMID: 22299123.
  15. Hamamoto DT, Rhodus NL. Methamphetamine abuse and dentistry. Oral Dis 2009;15(1):27–37. DOI: 10.1111/j.1601-0825.2008.01459.x
  16. Curtis EK. Meth mouth: a review of methamphetamine abuse and its oral manifestations. Gen Den 2006;54(2):125–129. PMID: 16689071.
  17. C Mariotti K, G Rossato L, E Froehlich P, et al. Amphetamine-type medicines: a review of pharmacokinetics, pharmacodynamics, and toxicological aspects. Curr Clin Pharmacol 2013;8(4):350–357. DOI: 10.2174/15748847113089990052
  18. Baig AM. DARK side of amphetamine and analogs: pharmacology, syndromic manifestation, and management of amphetamine addiction. ACS Chem Neurosci 2018;9(10):2299–2303. DOI: 10.1021/acschemneuro.8b00137
  19. Meth Mouth. https://www.pravara.com/pmr/pmr-6-4-3.pdf (accessed 28 April 2022)
  20. Frese PA, Elizabeth McClure RD. Methamphetamine: implications for the dental team. Crest Oral–B Continuing Education Course 2016:1–9.
  21. Klasser GD, Epstein J. Methamphetamine and its impact on dental care. J Can Dent Assoc 2005;71(10):759–762. PMID: 16324229.
  22. National Institute on Drug Abuse (NIDA). https://www.nih.gov/about-nih/what-we-do/nih-almanac/national-institute-drug-abuse-nida. (accessed 28 April 2022)
  23. Padilla R, Ritter AV. Meth mouth: methamphetamine and oral health. J Esthet Restor Dent 2008;20(2):148–149. DOI: 10.1111/j.1708-8240.2008.00167.x
  24. Goodchild JH, Donaldson M. Methamphetamine abuse and dentistry: a review of the literature and presentation of a clinical case. Quintessence Int 2007;38(7):583–590. PMID: 17694215.
  25. McGrath C, Chan B. Oral health sensations associated with illicit drug abuse. Br Dent J 2005;198(3):159–162. DOI: 10.1038/sj.bdj.4812050
  26. Griffin JP, O’Grady J, editors. The textbook of pharmaceutical medicine. Blackwell; 2006.
  27. Greenspan D. Xerostomia: diagnosis and management. Oncology (Williston Park, NY) 1996;10(3 Suppl):7–11. PMID: 8723427.
  28. Rhodus NL, Little JW. Methamphetamine abuse and” meth mouth”. Pa Dent J (Harrisb) 2005;84(5):19–29. PMID: 16317979.
  29. Shaner JW, Kimmes N, Saini T, et al. “Meth mouth”: rampant caries in methamphetamine abusers. AIDS Patient Care STDs 2006;20(3):146–150. DOI: 10.1089/apc.2006.20.146
  30. Heng CK, Badner VM, Schiop LA. Meth mouth. N Y State Dent J 2008;74(5):50–51. PMID: 18982966.
  31. Milosevic A, Agrawal N, Redfearn P, et al. The occurrence of tooth wear in users of Ecstasy (3, 4 MethyleneDioxyMethAmphetamine). Community Dent Oral Epidemiol 1999;27(4):283–287. DOI: 10.1111/j.1600-0528.1999.tb02022.x
  32. Vinayak V, Annigeri RG, Mittal S, et al. Drug induced disorders of teeth-a review. Indian Journal of Contemporary Dentistry 2013;1(1):88. DOI: 10.5958/j.2320-5962.1.1.020
  33. Turkyilmaz I. Oral manifestations of “meth mouth”: a case report. Contemp Dent Pract 2010;11(1):E073–E080. PMID: 20098969.
  34. Buzalaf MA, Hannas AR, Kato MT. Saliva and dental erosion. J Appl Oral Sci 2012;20(5):493–502. DOI: 10.1590/s1678-77572012000500001
  35. Amaechi BT, Higham SM. Eroded enamel lesion remineralization by saliva as a possible factor in the site-specificity of human dental erosion. Arch Oral Biol 2001;46(8):697–703. DOI: 10.1016/s0003-9969(01)00034-6
  36. Navarro M, Pichini S, Farré M, et al. Usefulness of saliva for measurement of 3, 4-methylenedioxymethamphetamine and its metabolites: correlation with plasma drug concentrations and effect of saliva ry pH. Clin Chem 2001;47(10):1788–1795. PMID: 11568088.
  37. Clague J, Belin TR, Shetty V. Mechanisms underlying methamphetamine-related dental disease. J Am Dent Assoc 2017;148(6):377–386. DOI: 10.1016/j.adaj.2017.02.054
  38. Laslett AM, Crofts JN. Meth mouth. Med J Aust 2007;186(12):661. DOI: 10.5694/j.1326-5377.2007.tb01093.x
  39. Macknelly A, Day J. A survey of techniques to reduce and manage external beam radiation-induced xerostomia in British oncology and radiotherapy departments. Radiography 2009;41(9):283–291. DOI: 10.1016/j.radi.2009.01.002
  40. McDaniel TF, Miller D, Jones R, et al. Assessing patient willingness to reveal health history information. J Am Dent Assoc 1995;126(3):375–379. DOI: 10.14219/jada.archive.1995.0183
  41. McGee SM, McGee DN, McGee MB. Spontaneous intracerebral hemorrhage related to methamphetamine abuse: autopsy findings and clinical correlation. Am J Forensic Med Pathol 2004;25(4):334–337. DOI: 10.1097/01.paf.0000137206.16785.2f
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.